Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.
The assays use a two-step immunometric design, minimising the risk of high-dose-hook and ensuring that the measurement of samples with elevated PSA levels will generate appropriate results. No high-dose-hook has been observed at PSA concentrations up to 160,000 µg/L, according to Olympus.
Other available test panels for the AU30001 include the primary tumour marker panel (AFP, CEA, PSA and fPSA) and the specialist tumour markers GI TN-TC and BR-TC.
Phone: 03 9265 5400
3M Petrifilm Plates and Plate Reader
The 3M Petrifilm Plates and Plate Reader are designed to distil the complexity, variability and...
3M Molecular Detection System
The 3M Molecular Detection System is designed to help save time and labour with its ready-to-use...
3M Clean-Trace ATP-based Hygiene Monitoring and Management System
The 3M Clean-Trace ATP-based Hygiene Monitoring and Management System features a Luminometer LM1...
